Nivolumab-induced acute neutrophilic gastritis: Case report in a tertiary hospital

Ojeda Gómez, Asunción; Pamies Ramón, Maria Isabel; Brotons Brotons, Alicia; Jiménez García, Nuria; Picó Sala, Maria Dolores; Cabezas Macian, María; Vera Sánchez, Javier Sola; García Sepulcre, Mariana Fe

doi:10.1016/j.gastre.2023.01.012

array:22 ["pii" => "S2444382424000105" "issn" => "24443824" "doi" => "10.1016/j.gastre.2023.01.012" "estado" => "S300" "fechaPublicacion" => "2024-01-01" "aid" => "2042" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2024;47:74-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S2444382424000130" "issn" => "24443824" "doi" => "10.1016/j.gastre.2023.02.006" "estado" => "S300" "fechaPublicacion" => "2024-01-01" "aid" => "2058" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2024;47:75-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Scientific letter" "titulo" => "Peripancreatic lymphangioma: When fine needle aspiration changes the diagnosis—Case report and literary review" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "75" "paginaFinal" => "77" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Linfangioma peripancreático: cuando la aspiración con aguja fina cambia el diagnóstico. Reporte de caso y revisión de la literatura" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2548 "Ancho" => 2508 "Tamanyo" => 372255 ] ] "descripcion" => array:1 [ "en" => "(A) Peripancreatic cystic lesion (peripancreatic lymphangioma); (B) EUS-FNA of cystic lesion; (C) Milky fluid obtained from EUS-FNA." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Inês Pestana, Ana Caldeira, Mara Costa, Rui Sousa, Eduardo Pereira, António Banhudo" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Inês" "apellidos" => "Pestana" ] 1 => array:2 [ "nombre" => "Ana" "apellidos" => "Caldeira" ] 2 => array:2 [ "nombre" => "Mara" "apellidos" => "Costa" ] 3 => array:2 [ "nombre" => "Rui" "apellidos" => "Sousa" ] 4 => array:2 [ "nombre" => "Eduardo" "apellidos" => "Pereira" ] 5 => array:2 [ "nombre" => "António" "apellidos" => "Banhudo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382424000130?idApp=UINPBA00004N" "url" => "/24443824/0000004700000001/v2_202405290645/S2444382424000130/v2_202405290645/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2444382424000099" "issn" => "24443824" "doi" => "10.1016/j.gastre.2023.01.011" "estado" => "S300" "fechaPublicacion" => "2024-01-01" "aid" => "2041" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2024;47:72-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Scientific letter" "titulo" => "Cyclosporine treatment for severe steroid refractory immune-mediated colitis in a patient with ulcerative colitis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "72" "paginaFinal" => "73" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ciclosporina como tratamiento de colitis inmunomediada grave refractaria a esteroides en un paciente con colitis ulcerosa" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 784 "Ancho" => 2523 "Tamanyo" => 156012 ] ] "descripcion" => array:1 [ "en" => "Evolution of the patient's stool frequency and RCP." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Gerard Grau, Ariadna Altadill, Eduard Brunet-Mas, Xavier Calvet" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Gerard" "apellidos" => "Grau" ] 1 => array:2 [ "nombre" => "Ariadna" "apellidos" => "Altadill" ] 2 => array:2 [ "nombre" => "Eduard" "apellidos" => "Brunet-Mas" ] 3 => array:2 [ "nombre" => "Xavier" "apellidos" => "Calvet" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382424000099?idApp=UINPBA00004N" "url" => "/24443824/0000004700000001/v2_202405290645/S2444382424000099/v2_202405290645/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Scientific letter" "titulo" => "Nivolumab-induced acute neutrophilic gastritis: Case report in a tertiary hospital" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "74" "paginaFinal" => "75" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Asunción Ojeda Gómez, Maria Isabel Pamies Ramón, Alicia Brotons Brotons, Nuria Jiménez García, Maria Dolores Picó Sala, María Cabezas Macian, Javier Sola Vera Sánchez, Mariana Fe García Sepulcre" "autores" => array:8 [ 0 => array:4 [ "nombre" => "Asunción" "apellidos" => "Ojeda Gómez" "email" => array:1 [ 0 => "asunojedagomez@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Maria Isabel" "apellidos" => "Pamies Ramón" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Alicia" "apellidos" => "Brotons Brotons" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Nuria" "apellidos" => "Jiménez García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "Maria Dolores" "apellidos" => "Picó Sala" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 5 => array:3 [ "nombre" => "María" "apellidos" => "Cabezas Macian" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 6 => array:3 [ "nombre" => "Javier Sola" "apellidos" => "Vera Sánchez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 7 => array:3 [ "nombre" => "Mariana Fe" "apellidos" => "García Sepulcre" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "General University Hospital of Elche, Digestive Care Service, Elche, Alicante, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "General University Hospital of Elche, Oncology Service, Elche, Alicante, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "General University Hospital of Elche, Anatomopathology Service, Elche, Alicante, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Gastritis aguda inducida por nivolumar: a propósito de una serie de casos recogidos en un hospital terciario" ] ] "textoCompleto" => "Immune check-point blockade agents have become the standard of care for an increasing number of indications over the last few years. These drugs are associated with immune-related adverse events (irAEs) whose incidence varies depending on the immune check-points which are being inhibited. Gastrointestinal toxicity from cancer immunotherapy appears to be more frequent for anti-CTLA-4 than for anti-PD1 or anti-PD-L1, the target of Nivolumab.<a class="elsevierStyleCrossRef" href="#bib0030">1</a> Although irAEs including the lower gastrointestinal tract are well known in anti-PD1 treatment; the gastritis or the esophagitis remain sporadic effects.<a class="elsevierStyleCrossRef" href="#bib0035">2</a> In our center, two cases of acute pangastritis have been reported in one year.We carried out a retrospective, descriptive study. We reviewed the clinical history of those patients who had received Nivolumab for any indication from January 2017 to December 2021 in our tertiary center. We selected those with upper gastrointestinal symptoms and for whom an upper gastrointestinal diagnosis had been reached by an esophagogastroduodenoscopy (OGD).Of the overall 100 patients treated with Nivolumab in this period, two cases of gastritis were detected, which supposes an incidence rate of 2% (IC 95% −0.007, 0.047). The first patient was a 47 years-aged man with a personal history of malignant non-metastatic melanoma (pT3bN2M0) radically removed. He underwent adjuvant therapy with Nivolumab for recurrence prevention and was admitted to our ward with epigastric pain and hyporexia. The second patient was a 64 year-old woman diagnosed with a metastatic choroidal melanoma previously treated with local surgery who reported epigastric pain in the last month. In both cases the symptoms started just after receiving the 9th dose of treatment which corresponds to 4.5 months follow-up period. Their basal characteristics are summarized in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. For the two cases, preferential ODG were performed, showing an intense inflammation throughout the stomach. Macroscopically, the mucosa was erythematous, edematous, with friability and extense ulcerations covered with fibrine. In both cases the biopsies taken revealed inflammatory neutrophilic infiltration into the epithelium, as well as cellular apoptosis and crypt microabscesses, all of which was related to Nivolumab drug-induced pangastritis. No form of Helicobacter Pylori was identified in any case. CMV determinations by IHQ and biopsies were also negative. Medical treatment with double-dose of proton-pump inhibitor and definitive cessation of Nivolumab was established, becoming the first patient rapidly asymptomatic. However our second patient didn’t show any improvement after several weeks of oral treatment so she remained hospitalized with IV corticosteroids, observing a complete remission of his symptoms.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>Nivolumab is a PD-L1 inhibitor extendedly used in metastatic, locally advanced or recurrent malignant diseases such as melanoma, non-small-cell lung cancer, renal cell or urothelial carcinoma, Hodgkin's disease, and squamous cell carcinoma of the head and neck.<a class="elsevierStyleCrossRef" href="#bib0030">1</a> It leads to the activation of the cytotoxic immune response which is normally carried out by LT-CD8 against malignant cells.<a class="elsevierStyleCrossRef" href="#bib0030">1</a> The immune-mediated gastritis is a rare adverse event, which can appear several months after the beginning of the treatment but also after its discontinuation. The differential diagnosis must be reached by excluding infectious gastritis, vasculitis, Crohn's disease or Behçet syndrome. The pathologist must always know the involvement of this treatment in order to achieve a reliable diagnosis.<a class="elsevierStyleCrossRef" href="#bib0040">3</a> The role of Helicobater Pylori must be highlighted in this case. Since it is capable of simulating or even worsening the immune mediated gastritis, not only its identification but also its eradication becomes essential.<a class="elsevierStyleCrossRef" href="#bib0045">4</a> The treatment is based on the immediate cessation of the immunotherapy, the gastric acid suppression and high doses of corticosteroids in the most severe cases. Benefits of immunosuppressive treatment using infliximab have been shown in refractory cases.<a class="elsevierStyleCrossRef" href="#bib0050">5</a>Conflict of interestsThe authors declare no conflict of interests." "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interests" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Patient 1 \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Patient 2 \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Age \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">47 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">64 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Sex \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Female \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Tumor \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Skin melanoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Choroidal melanoma \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage of disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage III \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Stage IV \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cycles of nivolumab \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Previous immune-related adverse events \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">History of autoimmune disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Helicobacter pylori \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Previous treatment with immunotherapy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3552204.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Basal characteristics of the two patients receiving nivolumab who developed an acute gastritis." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gastritis inducida por nivolumab en un paciente con melanoma metastásico" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Martínez" 1 => "B. Busto" 2 => "C. Cerezo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rgmx.2020.07.012" "Revista" => array:6 [ "tituloSerie" => "Revista de Gastroenterología de México" "fecha" => "2021" "volumen" => "86" "paginaInicial" => "90" "paginaFinal" => "91" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33309401" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nivolumab-induced concomitant severe upper and lower gastrointestinal immune-related adverse effects" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Alhatem" 1 => "K. Patel" 2 => "B. Eriksen" 3 => "S. Bukhari" 4 => "C. Liu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.14309/crj.0000000000000249" "Revista" => array:5 [ "tituloSerie" => "ACG Case Rep J" "fecha" => "2019" "volumen" => "6" "paginaInicial" => "e00249" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32309466" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Endoscopic evaluation of immunotherapy-induced gastrointestinal toxicity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "I. Iranzo" 1 => "J. Huguet" 2 => "P. Suárez" 3 => "L. Ferrer-Barceló" 4 => "V. Iranzo" 5 => "J. Sempere" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4253/wjge.v10.i12.392" "Revista" => array:6 [ "tituloSerie" => "World J Gastrointest Endosc" "fecha" => "2018" "volumen" => "10" "paginaInicial" => "392" "paginaFinal" => "399" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30631403" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical characteristics and outcomes of gastritis associated with immune checkpoint inhibitors: scoping review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Obeidat" 1 => "K. Silangcruz" 2 => "L. Kozai" 3 => "E. Wien" 4 => "Y. Fujiwara" 5 => "Y. Nishimura" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/CJI.0000000000000435" "Revista" => array:6 [ "tituloSerie" => "J Immunother" "fecha" => "2022" "volumen" => "45" "paginaInicial" => "363" "paginaFinal" => "369" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35972801" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Severe steroid refractory gastritis induced by Nivolumab: a case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "H. Vindum" 1 => "J. Agnholt" 2 => "A. Nielsen" 3 => "M.B. Nielsen" 4 => "H. Schmidt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v26.i16.1971" "Revista" => array:6 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2020" "volumen" => "26" "paginaInicial" => "1971" "paginaFinal" => "1978" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32390707" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/24443824/0000004700000001/v2_202405290645/S2444382424000105/v2_202405290645/en/main.assets" "Apartado" => array:4 [ "identificador" => "77930" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letter" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/24443824/0000004700000001/v2_202405290645/S2444382424000105/v2_202405290645/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382424000105?idApp=UINPBA00004N"]

ISSN: 2444-3824

Gastroenterology and Hepatology is the first journal to cover the latest advances in pathology of the gastrointestinal tract, liver, pancreas, and bile ducts, making it an indispensable tool for gastroenterologists, hepatologists, internists and general practitioners. In addition to the rigorously selected, systematically peer-reviewed manuscripts published in the research sections (Original Articles, Scientific Letters, Editorials, and Letters to the Editor), the journal also contains other important sections, such as Review Articles and Clinical Decision-Making Support, which offer in-depth reviews and updates on issues relating to the specialty.

See more Open Access Option

Indexed in:

SCIE/Journal of Citation Reports, Index Medicus/Medline, Excerpta Medica/EMBASE, SCOPUS, CANCERLIT, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.263

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.306

View more metrics

Journal Information

Previous article | Next article

Vol. 47. Issue 1.